• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞来源的外泌体治疗诱导型 1 型糖尿病大鼠的效果。

The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats.

机构信息

Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Giza, Egypt.

Pathology Department, Faculty of Medicine, Cairo University, Giza, Egypt.

出版信息

Biotechnol Lett. 2020 Aug;42(8):1597-1610. doi: 10.1007/s10529-020-02908-y. Epub 2020 May 19.

DOI:10.1007/s10529-020-02908-y
PMID:32430801
Abstract

AIM

The aim of the current study was to evaluate the therapeutic and regenerative effects of MSCs derived exosomes in the treatment of type 1 DM and to compare its effects with MSCs themselves. The experiment was done on forty albino rats grouped as follows, group (1): Ten healthy rats, group (2): Ten induced type 1 DM rats, group (3): Ten induced type 1 DM rats received exosomes intraperitoneally, and group (4): Ten induced type 1 DM rats received MSCs intraperitoneally. Serum glucose and plasma insulin levels were assessed weekly. QRT-PCR was done to assess regeneration of pancreatic beta cells by measuring insulin, Pdx1, Smad2, Smad3 and TGFβ genes. Additionally, histopathological and immune-histochemical examinations were done to confirm pancreatic tissue regeneration.

RESULTS

Regarding the assessed genes (insulin, Pdx1, Smad2, Smad3 and Tgfβ) gene expression in MSCs treated group showed significant increase compared to diabetic group (p value < 0.001) and gene expression in exosomes treated group was increased significantly compared to diabetic and MSCs treated groups (p value < 0.001). Histopathological and immune-histochemical examination revealed regeneration of pancreatic islets in both treated groups.

CONCLUSION

MSCs Derived exosomes showed superior therapeutic and regenerative results than MSCs themselves.

摘要

目的

本研究旨在评估间充质干细胞衍生的外泌体在 1 型糖尿病治疗中的治疗和再生效果,并将其与间充质干细胞本身的效果进行比较。实验在 40 只白化大鼠中进行,分为以下几组:第 1 组:10 只健康大鼠;第 2 组:10 只诱导的 1 型糖尿病大鼠;第 3 组:10 只诱导的 1 型糖尿病大鼠腹腔内注射外泌体;第 4 组:10 只诱导的 1 型糖尿病大鼠腹腔内注射间充质干细胞。每周评估血清葡萄糖和血浆胰岛素水平。通过测量胰岛素、Pdx1、Smad2、Smad3 和 TGFβ 基因,进行 QRT-PCR 评估胰腺β细胞的再生情况。此外,进行组织病理学和免疫组织化学检查以确认胰腺组织再生。

结果

关于评估的基因(胰岛素、Pdx1、Smad2、Smad3 和 Tgfβ),间充质干细胞治疗组的基因表达与糖尿病组相比显著增加(p 值 < 0.001),外泌体治疗组的基因表达与糖尿病组和间充质干细胞治疗组相比显著增加(p 值 < 0.001)。组织病理学和免疫组织化学检查显示两组均有胰岛再生。

结论

与间充质干细胞相比,间充质干细胞衍生的外泌体显示出更好的治疗和再生效果。

相似文献

1
The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats.间充质干细胞来源的外泌体治疗诱导型 1 型糖尿病大鼠的效果。
Biotechnol Lett. 2020 Aug;42(8):1597-1610. doi: 10.1007/s10529-020-02908-y. Epub 2020 May 19.
2
Potential of stem cell-derived exosomes to regenerate β islets through Pdx-1 dependent mechanism in a rat model of type 1 diabetes.干细胞衍生的外泌体通过 Pdx-1 依赖机制在 1 型糖尿病大鼠模型中再生β胰岛的潜力。
J Cell Physiol. 2019 Nov;234(11):20310-20321. doi: 10.1002/jcp.28631. Epub 2019 Apr 17.
3
Mesenchymal stem cell-derived exosomes improve diabetes mellitus-induced myocardial injury and fibrosis via inhibition of TGF-β1/Smad2 signaling pathway.间充质干细胞衍生的外泌体通过抑制TGF-β1/Smad2信号通路改善糖尿病诱导的心肌损伤和纤维化。
Cell Mol Biol (Noisy-le-grand). 2019 Sep 30;65(7):123-126.
4
Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus.脂肪组织来源的干细胞分化为胰岛素产生细胞在1型糖尿病治疗中的作用。
Gene. 2018 May 15;654:87-94. doi: 10.1016/j.gene.2018.02.008. Epub 2018 Feb 13.
5
Breast milk MSCs upregulated β-cells PDX1, Ngn3, and PCNA expression via remodeling ER stress /inflammatory /apoptotic signaling pathways in type 1 diabetic rats.母乳间充质干细胞通过重塑 1 型糖尿病大鼠的 ER 应激/炎症/凋亡信号通路,上调β细胞 PDX1、Ngn3 和 PCNA 的表达。
Eur J Pharmacol. 2021 Aug 15;905:174188. doi: 10.1016/j.ejphar.2021.174188. Epub 2021 May 15.
6
Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.间充质干细胞和分化的胰岛素产生细胞是I型糖尿病胰腺再生的新方向。
Int J Biochem Cell Biol. 2017 Jun;87:77-85. doi: 10.1016/j.biocel.2017.03.018. Epub 2017 Apr 3.
7
Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model.水飞蓟宾对胰腺切除模型中Pdx-1表达及胰腺β细胞增殖的影响。
Phytomedicine. 2014 Feb 15;21(3):233-9. doi: 10.1016/j.phymed.2013.09.008. Epub 2013 Oct 28.
8
Exosomes Secreted by Umbilical Cord Blood-Derived Mesenchymal Stem Cell Attenuate Diabetes in Mice.脐带血间充质干细胞分泌的外泌体可减轻小鼠糖尿病。
J Diabetes Res. 2021 Dec 10;2021:9534574. doi: 10.1155/2021/9534574. eCollection 2021.
9
Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.脂肪组织来源的间充质干细胞在实验性自身免疫性1型糖尿病同种异体胰岛复合移植中的免疫调节和保护作用
Immunol Lett. 2017 Aug;188:21-31. doi: 10.1016/j.imlet.2017.05.006. Epub 2017 May 12.
10
Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.同种异体间充质基质细胞移植对糖尿病大鼠高血糖和胰岛素缺乏改善作用的不同胰腺微环境影响。
J Surg Res. 2012 Nov;178(1):188-95. doi: 10.1016/j.jss.2012.02.028. Epub 2012 Mar 26.

引用本文的文献

1
The role and mechanism of mesenchymal stem cells in immunomodulation of type 1 diabetes mellitus and its complications: recent research progress and challenges: a review.间充质干细胞在1型糖尿病及其并发症免疫调节中的作用和机制:最新研究进展与挑战:综述
Stem Cell Res Ther. 2025 Jun 17;16(1):308. doi: 10.1186/s13287-025-04431-1.
2
Exosomes in inflammation and cancer: from bench to bedside applications.炎症与癌症中的外泌体:从实验台到临床应用
Mol Biomed. 2025 Jun 10;6(1):41. doi: 10.1186/s43556-025-00280-9.
3
Advancements in diabetes research and stem cell therapy: a concise review.
糖尿病研究与干细胞治疗的进展:简要综述
J Diabetes Metab Disord. 2025 May 29;24(1):130. doi: 10.1007/s40200-025-01638-0. eCollection 2025 Jun.
4
The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus.间充质干细胞衍生外泌体治疗糖尿病的潜力
Biomimetics (Basel). 2025 Jan 14;10(1):49. doi: 10.3390/biomimetics10010049.
5
Engineered extracellular vesicles as "supply vehicles" to alleviate type 1 diabetes.工程化细胞外囊泡作为缓解1型糖尿病的“供应载体”。
Extracell Vesicles Circ Nucl Acids. 2024 Nov 14;5(4):618-621. doi: 10.20517/evcna.2024.61. eCollection 2024.
6
Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives.基于人间质干细胞/基质细胞的疗法治疗糖尿病:实验和临床观点。
Stem Cell Res Ther. 2024 Oct 29;15(1):384. doi: 10.1186/s13287-024-03974-z.
7
Exosomes Derived from Bone Marrow Dendritic Cells Exhibit Protective and Therapeutic Potential Against Chemically Induced Chronic Pancreatitis in Rats.源自骨髓树突状细胞的外泌体对大鼠化学诱导的慢性胰腺炎具有保护和治疗潜力。
Inflammation. 2024 Oct 19. doi: 10.1007/s10753-024-02150-y.
8
Stem Cell-Based Acellular Therapy: Insight into Biogenesis, Bioengineering and Therapeutic Applications of Exosomes.基于干细胞的去细胞治疗:外泌体的发生、生物工程和治疗应用的深入了解。
Biomolecules. 2024 Jul 3;14(7):792. doi: 10.3390/biom14070792.
9
Exosomes in Action: Unraveling Their Role in Autoimmune Diseases and Exploring Potential Therapeutic Applications.发挥作用的外泌体:揭示其在自身免疫性疾病中的作用并探索潜在的治疗应用
Immune Netw. 2024 Feb 20;24(2):e12. doi: 10.4110/in.2024.24.e12. eCollection 2024 Apr.
10
Mesenchymal Stem Cell-Derived Exosomes Loaded with Selenium or Nano Selenium as a Novel Therapeutic Paradigm for Streptozotocin-Induced Type 1 Diabetes in Rats.负载硒或纳米硒的间充质干细胞衍生外泌体作为链脲佐菌素诱导的大鼠1型糖尿病的新型治疗模式
Biology (Basel). 2024 Apr 11;13(4):253. doi: 10.3390/biology13040253.